arrow
A

Antonio Pagliuca

University of London
H指数:59
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Results from the prospective phase 2 multicentre UK PBSC haplo trial using PTCy pre- or post-stem cells

前瞻性英国多中心外周血干细胞单倍体移植试验中使用PTCy在干细胞移植前或后的结果

2026-03-010
PRE
Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT)

Defibrotide用于儿童高危患者窦状阻塞综合征/静脉闭塞病(SOS/VOD)的预防:欧洲血液与骨髓移植学会(EBMT)的共识指南

2026-01-130
OAAI
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group

成人肝窦阻塞综合征/静脉闭塞性疾病的管理:国际专家小组的2025年展望

2025-04-220
PRE
Hematopoietic Stem Cell (HSC) Graft Cryopreservation Effects on Outcomes of Patients with Hematologic Malignancies: the Multicenter United Kingdom Experience During the COVID-19 Pandemic

造血干细胞(HSC)移植物冷冻保存对血液恶性肿瘤患者预后的影响:COVID-19疫情期间英国多中心经验

2025-04-080
PRE
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
2023-11-011
PRE
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial

Defibrotide联合最佳护理标准与单独最佳护理标准预防肝窦阻塞综合征 (HARMONY) 的比较: 一项随机、多中心、3期临床试验

2023-05-0120
PRE
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
2022-04-1154
OAAI
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting
2021-11-099
OAAI
SARS-CoV-2 infection in aplastic anemia
2021-10-2121
OAAI
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

成人血液系统恶性肿瘤患者的新型冠状病毒肺炎感染: 欧洲血液学协会调查 (EPICOVIDEHA)

2021-10-14227
OAAI
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London
2021-08-1639
OAAI